CN105153215A - Refining method for improving quality of imipenem key intermediate - Google Patents

Refining method for improving quality of imipenem key intermediate Download PDF

Info

Publication number
CN105153215A
CN105153215A CN201510452781.2A CN201510452781A CN105153215A CN 105153215 A CN105153215 A CN 105153215A CN 201510452781 A CN201510452781 A CN 201510452781A CN 105153215 A CN105153215 A CN 105153215A
Authority
CN
China
Prior art keywords
quality
imipenum
key intermediate
hexane
purification
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510452781.2A
Other languages
Chinese (zh)
Inventor
赵小泉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangsu Ruike Pharmaceutical Co Ltd
Original Assignee
Jiangsu Ruike Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangsu Ruike Pharmaceutical Co Ltd filed Critical Jiangsu Ruike Pharmaceutical Co Ltd
Priority to CN201510452781.2A priority Critical patent/CN105153215A/en
Publication of CN105153215A publication Critical patent/CN105153215A/en
Pending legal-status Critical Current

Links

Abstract

The invention discloses a refining method for improving the quality of an imipenem key intermediate. The method comprises the following steps of adding raw materials N-(4-methoxyphenyl)-4-acetyl-3-[1-(tert-butyl dimethyl-siloxy) ethyl] azetidinone and sodium acetate into a reaction bottle, and controlling the temperature to be within 0-10 DEG C, dropwise adding an oxidant for 3 hours; then, conducting a reaction for 16 hours at 20-25 DEG C, and controlling the reaction endpoint by high-performance liquid chromatography; and dropwise adding the sodium sulfite to neutralize excessive oxidant until the color of starch potassium iodide does not change after the reaction is finished, adding hexane to conduct extraction for 5 times, drying the mixed hexane with anhydrous sodium sulfate, reclaiming the hexane at a reduced pressure until the residue is dry, adding absolute methanol to conduct heating and dissolving, adding activated carbon, coudcting refluxing and insulating for 30 minutes, conducting filtering when the mixture is hot, cooling the filtrate to 5 DEG C below zero, filtering the filtrate, and baking the filter cake at 40 DEG C at a reduced pressure until the filter cake is dry so as to obtain a dried product. The method can be used for remarkably improving the product quality and has a remarkable economic benefit.

Description

A kind of process for purification improving the quality of imipenum key intermediate
Technical field
The invention belongs to basic chemical industry field, particularly relate to a kind of process for purification improving imipenum key intermediate N-(4-p-methoxy-phenyl)-4-acetoxy-3-{ 1-(tertiary butyl dimethyl Si base) ethyl } azetidinone quality.
Background technology
Imipenum key intermediate N-(4-p-methoxy-phenyl)-4-acetoxy-3-{ 1-(tertiary butyl dimethyl Si base) ethyl } azetidinone adopted hexane to make reaction, extraction solvent in the past, obtained N-(4-p-methoxy-phenyl)-4-acetoxy-3-{ 1-(tertiary butyl dimethyl Si base) ethyl } azetidinone through extraction liquid concentrating under reduced pressure.The problems such as it is low that the method mainly exists purity, and product by product is many, of poor quality, these ropy factors will directly have influence on the quality of the finished product imipenum.
Summary of the invention
The technical problem to be solved in the present invention is to provide a kind of process for purification improving the quality of imipenum key intermediate, not only can improve purity on the one hand, improve the quality of products; Can increase economic efficiency on the other hand.
For solving the problems of the technologies described above, the invention provides a kind of process for purification improving the quality of imipenum key intermediate, comprising the following steps:
(1) in reaction flask, add raw material N-(4-p-methoxy-phenyl)-4-ethanoyl-3-{1-(tertiary butyl dimethyl Si base) ethyl } azetidinone and sodium-acetate, temperature is controlled in 0-10 DEG C, drip oxygenant, time for adding is 3 hours, then react 16 hours at 20-25 DEG C, control reaction end by high performance liquid chromatography;
(2), after reaction terminates, drip oxygenant in S-WAT and excessive to starch potassium iodide nondiscoloration, add hexane and extract 5 times, solvent hexane remaining after merging 5 extractions, with anhydrous sodium sulfate drying, after reclaim under reduced pressure hexane is extremely dry, must residuum be distilled, add the anhydrous methanol heating for dissolving of described distillation residuum 6-8 times amount, then add gac, backflow insulation 30 minutes, filtered while hot, is chilled to-5 DEG C by filtrate, filters, filter cake 40 DEG C of decompression dryings, to dry, obtain dry product.
As a kind of a kind of preferred version improving the process for purification of the quality of imipenum key intermediate of the present invention, N-described in described step (1) (4-p-methoxy-phenyl)-4-ethanoyl-3-{1-(tertiary butyl dimethyl Si base) ethyl } mol ratio of azetidinone, sodium-acetate and oxygenant is 1:0.8:1.05.
As a kind of a kind of preferred version improving the process for purification of the quality of imipenum key intermediate of the present invention, described in described step (1), oxygenant is hydrogen peroxide.
As a kind of a kind of preferred version improving the process for purification of the quality of imipenum key intermediate of the present invention, described in described step (1), the weight percent of hydrogen peroxide is 50%.
As a kind of a kind of preferred version improving the process for purification of the quality of imipenum key intermediate of the present invention, the weight percent of S-WAT described in described step (2) is 10%.
As a kind of a kind of preferred version improving the process for purification of the quality of imipenum key intermediate of the present invention, described in described step (2), the addition of hexane is 200ml/ time.
As a kind of a kind of preferred version improving the process for purification of the quality of imipenum key intermediate of the present invention, described in described step (2), the addition of anhydrous sodium sulphate is 20g.
As a kind of a kind of preferred version improving the process for purification of the quality of imipenum key intermediate of the present invention, described in described step (2), the pressure of reclaim under reduced pressure hexane is vacuum tightness-0.09mpa.
As a kind of a kind of preferred version improving the process for purification of the quality of imipenum key intermediate of the present invention, described in described step (2), the weight percent of gac is 2%.
As a kind of a kind of preferred version improving the process for purification of the quality of imipenum key intermediate of the present invention, the pressure of filter cake 40 DEG C of decompression dryings described in described step (2) is for being vacuum tightness-0.09mpa.
The invention discloses a kind of process for purification improving imipenum key intermediate N-(4-p-methoxy-phenyl)-4-acetoxy-3-{ 1-(tertiary butyl dimethyl Si base) ethyl } azetidinone quality, this compound purity is made to bring up to about 99.75% from original 85.23%, quality product significantly improves, and has significant economic benefit.
Embodiment
The invention provides a kind of process for purification improving the quality of imipenum key intermediate, comprise the following steps:
(1) in reaction flask, add raw material N-(4-p-methoxy-phenyl)-4-ethanoyl-3-{1-(tertiary butyl dimethyl Si base) ethyl } azetidinone and sodium-acetate, temperature is controlled in 0-10 DEG C, drip oxygenant, time for adding is 3 hours, then react 16 hours at 20-25 DEG C, control reaction end by high performance liquid chromatography;
(2), after reaction terminates, drip oxygenant in S-WAT and excessive to starch potassium iodide nondiscoloration, add hexane and extract 5 times, solvent hexane remaining after merging 5 extractions, with anhydrous sodium sulfate drying, after reclaim under reduced pressure hexane is extremely dry, must residuum be distilled, add the anhydrous methanol heating for dissolving of described distillation residuum 6-8 times amount, then add gac, backflow insulation 30 minutes, filtered while hot, is chilled to-5 DEG C by filtrate, filters, filter cake 40 DEG C of decompression dryings, to dry, obtain dry product.
For enabling above-mentioned purpose of the present invention, feature and advantage become apparent more, and below in conjunction with embodiment, the present invention is further detailed explanation.
Improve a process for purification for the quality of imipenum key intermediate, comprising:
Step one: add raw material N-(4-p-methoxy-phenyl)-4-ethanoyl-3-{1-(tertiary butyl dimethyl Si base) ethyl in reaction flask } azetidinone and sodium-acetate, temperature is controlled in 0-10 DEG C, drip oxygenant, time for adding is 3 hours, then react 16 hours at 20-25 DEG C, control reaction end by high performance liquid chromatography; With
In one embodiment, this step can specific as followsly perform: in reaction flask, add raw material N-(4-p-methoxy-phenyl)-4-ethanoyl-3-{1-(tertiary butyl dimethyl Si base) ethyl } azetidinone and sodium-acetate, temperature is controlled in 0-10 DEG C, drip oxygenant, described oxygenant be weight percentage 50% hydrogen peroxide time for adding be 3 hours, then react 16 hours at 20-25 DEG C, reaction end is controlled by high performance liquid chromatography, wherein, described N-(4-p-methoxy-phenyl)-4-ethanoyl-3-{1-(tertiary butyl dimethyl Si base) ethyl } azetidinone, the mol ratio of sodium-acetate and oxygenant is 1:0.8:1.05.
Step 2: after reaction terminates, drips oxygenant in S-WAT and excessive to starch potassium iodide nondiscoloration, adds hexane and extract 5 times, solvent hexane remaining after merging 5 extractions, with anhydrous sodium sulfate drying, after reclaim under reduced pressure hexane is extremely dry, must residuum be distilled, add the anhydrous methanol heating for dissolving of described distillation residuum 6-8 times amount, then add gac, backflow insulation 30 minutes, filtered while hot, is chilled to-5 DEG C by filtrate, filters, filter cake 40 DEG C of decompression dryings, to dry, obtain dry product.
In one embodiment, this step can specific as followsly perform: after reaction terminates, dripping weight percent is that in the S-WAT of 10% He excessive oxygenant is to starch potassium iodide nondiscoloration, add 200ml/ hexane and extract 5 times, solvent hexane 20g anhydrous sodium sulfate drying remaining after merging 5 extractions, be decompressed to vacuum tightness-0.09mpa and reclaim hexane to after dry, residuum must be distilled, add the anhydrous methanol heating for dissolving of described distillation residuum 6-8 times amount, add the gac that weight percent is 2% again, backflow insulation 30 minutes, filtered while hot, filtrate is chilled to-5 DEG C, filter, filter cake 40 DEG C is decompressed to vacuum tightness-0.09mpa dries to dry, obtain dry product.
For enabling above-mentioned purpose of the present invention, feature and advantage become apparent more, further illustrate technical scheme of the present invention below in conjunction with embodiment.But the invention is not restricted to listed embodiment, also should be included in other any known changes in interest field of the presently claimed invention.
First, alleged herein " embodiment " or " embodiment " refers to special characteristic, structure or the characteristic that can be contained at least one implementation of the present invention.Different local in this manual " in one embodiment " occurred not all refers to same embodiment, neither be independent or optionally mutually exclusive with other embodiments embodiment.
Secondly, that says in the present invention is all weight percentage to per-cent, and the per-cent of the content of the something in certain step described is ratio shared for reaction solution in this step.
Embodiment 1
In reaction flask, add N-(4-p-methoxy-phenyl)-4-ethanoyl-3-{1-(tertiary butyl dimethyl Si base) ethyl } azetidinone, sodium-acetate; 50% hydrogen peroxide is dripped in control 0-10 DEG C; time for adding about 3 hours; react 16 hours at 20-25 DEG C, control reaction end by high performance liquid chromatography.After reaction terminates, drip oxygenant in the S-WAT of 10% and excessive to starch potassium iodide nondiscoloration, add hexane and extract 5 times, merge hexane layer anhydrous sodium sulfate drying, after reclaim under reduced pressure hexane is extremely dry, add 6 times amount anhydrous methanol heating for dissolving, add the gac of theoretical amount 2% again, backflow insulation 30 minutes, filtered while hot, is chilled to-5 DEG C by filtrate, filter, filter cake 40 DEG C of decompression dryings are to dry, and lower batch of filtrate is applied mechanically, dry product purity 98.75%.
Embodiment 2
In reaction flask, add N-(4-p-methoxy-phenyl)-4-ethanoyl-3-{1-(tertiary butyl dimethyl Si base) ethyl } azetidinone, sodium-acetate; 50% hydrogen peroxide is dripped in control 0-10 DEG C; time for adding about 3 hours; react 16 hours at 20-25 DEG C, control reaction end by high performance liquid chromatography.After reaction terminates, drip oxygenant in the S-WAT of 10% and excessive to starch potassium iodide nondiscoloration, add hexane and extract 5 times, merge hexane layer anhydrous sodium sulfate drying, after reclaim under reduced pressure hexane is extremely dry, add 7 times amount anhydrous methanol heating for dissolving, add the gac of theoretical amount 2% again, backflow insulation 30 minutes, filtered while hot, is chilled to-5 DEG C by filtrate, filter, filter cake 40 DEG C of decompression dryings are to dry, and lower batch of filtrate is applied mechanically, dry product purity 99.15%.
Embodiment 3
In reaction flask, add N-(4-p-methoxy-phenyl)-4-ethanoyl-3-{1-(tertiary butyl dimethyl Si base) ethyl } azetidinone, sodium-acetate; 50% hydrogen peroxide is dripped in control 0-10 DEG C; time for adding about 3 hours; react 16 hours at 20-25 DEG C, control reaction end by high performance liquid chromatography.After reaction terminates, drip oxygenant in the S-WAT of 10% and excessive to starch potassium iodide nondiscoloration, add hexane and extract 5 times, merge hexane layer anhydrous sodium sulfate drying, after reclaim under reduced pressure hexane is extremely dry, add 8 times amount anhydrous methanol heating for dissolving, add the gac of theoretical amount 2% again, backflow insulation 30 minutes, filtered while hot, is chilled to-5 DEG C by filtrate, filter, filter cake 40 DEG C of decompression dryings are to dry, and lower batch of filtrate is applied mechanically, dry product purity 99.75%.
Imipenum key intermediate N-(4-the p-methoxy-phenyl)-4-acetoxy-3 that embodiment 1 ~ 3 obtains-{ 1-(tertiary butyl dimethyl Si base) ethyl } azetidinone quality meets inner controlling standard of enterprise.
In sum, the invention discloses a kind of process for purification improving imipenum key intermediate N-(4-p-methoxy-phenyl)-4-acetoxy-3-{ 1-(tertiary butyl dimethyl Si base) ethyl } azetidinone quality, remarkable advantage of the present invention:
The purity of 1, imipenum key intermediate N-(4-p-methoxy-phenyl)-4-acetoxy-3 described in present method-{ 1-(tertiary butyl dimethyl Si base) ethyl } azetidinone brings up to 99.75% by original 85.23%;
2, present method is owing to improve imipenum key intermediate N-(4-p-methoxy-phenyl)-4-acetoxy-3-{ 1-(tertiary butyl dimethyl Si base) ethyl } azetidinone quality, so make imipenum subsequent reactions yield and quality have also been obtained raising.
It should be noted that, above embodiment is only in order to illustrate technical scheme of the present invention and unrestricted, although with reference to preferred embodiment to invention has been detailed description, those of ordinary skill in the art is to be understood that, can modify to technical scheme of the present invention or equivalent replacement, and not departing from the spirit and scope of technical solution of the present invention, it all should be encompassed in the middle of right of the present invention.

Claims (10)

1. improve a process for purification for the quality of imipenum key intermediate, it comprises:
(1) in reaction flask, add raw material N-(4-p-methoxy-phenyl)-4-ethanoyl-3-{1-(tertiary butyl dimethyl Si base) ethyl } azetidinone and sodium-acetate, temperature is controlled in 0-10 DEG C, drip oxygenant, time for adding is 3 hours, then react 16 hours at 20-25 DEG C, control reaction end by high performance liquid chromatography;
(2), after reaction terminates, drip oxygenant in S-WAT and excessive to starch potassium iodide nondiscoloration, add hexane and extract 5 times, solvent hexane remaining after merging 5 extractions, with anhydrous sodium sulfate drying, after reclaim under reduced pressure hexane is extremely dry, must residuum be distilled, add the anhydrous methanol heating for dissolving of described distillation residuum 6-8 times amount, then add gac, backflow insulation 30 minutes, filtered while hot, is chilled to-5 DEG C by filtrate, filters, filter cake 40 DEG C of decompression dryings, to dry, obtain dry product.
2. the as claimed in claim 1 process for purification improving the quality of imipenum key intermediate, is characterized in that: N-described in described step (1) (4-p-methoxy-phenyl)-4-ethanoyl-3-{1-(tertiary butyl dimethyl Si base) ethyl } mol ratio of azetidinone, sodium-acetate and oxygenant is 1:0.8:1.05.
3. the process for purification improving the quality of imipenum key intermediate as claimed in claim 1, is characterized in that: described in described step (1), oxygenant is hydrogen peroxide.
4. the process for purification improving the quality of imipenum key intermediate as claimed in claim 3, is characterized in that: described in described step (1), the weight percent of hydrogen peroxide is 50%.
5. the process for purification improving the quality of imipenum key intermediate as claimed in claim 1, is characterized in that: described in described step (2), the weight percent of S-WAT is 10%.
6. the process for purification improving the quality of imipenum key intermediate as claimed in claim 1, is characterized in that: described in described step (2), the addition of hexane is 200ml/ time.
7. the process for purification improving the quality of imipenum key intermediate as claimed in claim 1, is characterized in that: described in described step (2), the addition of anhydrous sodium sulphate is 20g.
8. the process for purification improving the quality of imipenum key intermediate as claimed in claim 1, is characterized in that: described in described step (2), the pressure of reclaim under reduced pressure hexane is vacuum tightness-0.09mpa.
9. the process for purification improving the quality of imipenum key intermediate as claimed in claim 1, is characterized in that: described in described step (2), the weight percent of gac is 2%.
10. the process for purification improving the quality of imipenum key intermediate as claimed in claim 1, is characterized in that: described in described step (2), the pressure of filter cake 40 DEG C of decompression dryings is vacuum tightness-0.09mpa.
CN201510452781.2A 2015-07-28 2015-07-28 Refining method for improving quality of imipenem key intermediate Pending CN105153215A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510452781.2A CN105153215A (en) 2015-07-28 2015-07-28 Refining method for improving quality of imipenem key intermediate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510452781.2A CN105153215A (en) 2015-07-28 2015-07-28 Refining method for improving quality of imipenem key intermediate

Publications (1)

Publication Number Publication Date
CN105153215A true CN105153215A (en) 2015-12-16

Family

ID=54794300

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510452781.2A Pending CN105153215A (en) 2015-07-28 2015-07-28 Refining method for improving quality of imipenem key intermediate

Country Status (1)

Country Link
CN (1) CN105153215A (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008007836A1 (en) * 2006-07-13 2008-01-17 Choongwae Pharma Corporation Method for preparing 4-acetoxyazetidinone and derivatives thereof
CN101747250A (en) * 2008-12-16 2010-06-23 上海医药工业研究院 Method for preparing 4 - acyloxo heterocyclic ketone compounds
CN102002066A (en) * 2010-11-01 2011-04-06 山东鑫泉医药中间体有限公司 Synthesis method of 4-acetoxyl-2-azetidinone
CN102936262A (en) * 2012-11-07 2013-02-20 凯莱英医药集团(天津)股份有限公司 Preparation method for imipenem medicine intermediate 4AA
CN103665021A (en) * 2013-12-03 2014-03-26 西安赛美科医药研发有限公司 Synthetic method of biapenem drug intermediate 4-AA

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008007836A1 (en) * 2006-07-13 2008-01-17 Choongwae Pharma Corporation Method for preparing 4-acetoxyazetidinone and derivatives thereof
CN101747250A (en) * 2008-12-16 2010-06-23 上海医药工业研究院 Method for preparing 4 - acyloxo heterocyclic ketone compounds
CN102002066A (en) * 2010-11-01 2011-04-06 山东鑫泉医药中间体有限公司 Synthesis method of 4-acetoxyl-2-azetidinone
CN102936262A (en) * 2012-11-07 2013-02-20 凯莱英医药集团(天津)股份有限公司 Preparation method for imipenem medicine intermediate 4AA
CN103665021A (en) * 2013-12-03 2014-03-26 西安赛美科医药研发有限公司 Synthetic method of biapenem drug intermediate 4-AA

Similar Documents

Publication Publication Date Title
CN108147945B (en) Method for producing high-purity m-cresol
CN109126839A (en) A kind of composite catalyst composition and the method for preparing 2,4-/3,4- dichlorotoleune
CN105153215A (en) Refining method for improving quality of imipenem key intermediate
CN110947375A (en) Catalyst for preparing propylene oxide and preparation method thereof
CN105777802B (en) A kind of process for purification of butyl titanate
CN102320975A (en) Method for refining tri-n-octyl trimellitate and used refining agent thereof
CN106673937A (en) Method of preparing propylene by catalytic cracking of n-butene
CN110964538A (en) Transposition method of 1-cyclohexyl-2, 3-difluorobenzene
CN106518666A (en) Preparation method for refining dibutyl adipate
CN105272853A (en) Preparation method for diisooctyl adipate
CN106669793A (en) Modified ZSM-5 molecular sieve and preparation method and application thereof
CN110002983B (en) Method for reducing isomerization of beta-ionone in rectification process
CN117430535A (en) Catalyst for producing dimethyl sulfoxide and preparation method of dimethyl sulfoxide
CN101891611B (en) Method for preparing dipropyl adipate
CN101712599A (en) Method for preparing allyl pentaerythritol
CN115850033A (en) Synthetic method of guaiacol
CN109534941B (en) Method for extracting alpha-methyl styrene dimer from phenol tar
CN107541255A (en) A kind of method of alumina composite graphene carrier hydrogenation catalyst Porous deproteinized bone production isoheptane solvent naphtha
CN108017506B (en) Method for preparing 1-chloronaphthalene
CN106669798A (en) Non-hydrogen modified catalyst and preparation method and application thereof
CN107814710A (en) The method for preparing butyl caprylate
KR20180117954A (en) Aluminum oxide catalyst coated with heterogeneous graphitic carbon nitride, method for preparation of the catalyst, and method for removal of naphthenic acid in high acid crude oil
CN106675621A (en) Inferior gasoline non-hydrogen modification method
CN101712598A (en) Method for preparing trimethylolpropane allyl ether
CN105153075A (en) After-treatment method for improving purity of imipenem key midbody 2, 3-epoxybutylate

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
CB02 Change of applicant information

Address after: 224100 Yancheng City Dafeng marine biological medicine industrial park

Applicant after: Jiangsu Ruike medicine science and Technology Co Ltd

Address before: 224145 Yancheng City marine biological medicine industry park, Jiangsu Province

Applicant before: JIANGSU RUIKE PHARMACEUTICAL CO., LTD.

COR Change of bibliographic data
RJ01 Rejection of invention patent application after publication

Application publication date: 20151216

RJ01 Rejection of invention patent application after publication